How much risk are female cancer survivors willing to take to get pregnant by autotransplantation of cryopreserved ovarian cortex tissue

Completed

• Conditions: freezing ovarian tissue; Ovarian tissue cryopreservation; 10038612

• Registration Number: NL-OMON55348
• Lead Sponsor: Obstetrie en gynaecologie

Brief Summary

Trial ended prematurely

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 15

Inclusion Criteria

- Age 18 years or older
- Cryopreserved ovarian tissue, oocytes or embryo*s for oncological reasons at
Erasmus MC, LUMC or Radboudumc

Exclusion Criteria

- Severely diseased women
- Currently treated for malignancy
- Psychological problems
- Age below 18 years
- Deceased
- No knowledge of the Dutch language

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Outcome of the focus group with the aspects women find important in regard to<br /><br>fertility counselling after previous fertility preservation and<br /><br>autotransplantation of cryopreserved ovarian tissue. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p><br>